Repeated provocation of time- and ATP-induced early pulmonary vein reconnections after pulmonary vein isolation: eliminating paroxysmal atrial fibrillation in a single procedure

Circ Arrhythm Electrophysiol. 2011 Oct;4(5):601-8. doi: 10.1161/CIRCEP.110.960138. Epub 2011 Aug 13.

Abstract

Background: Recurrence of atrial fibrillation (AF) after successful pulmonary vein isolation (PVI) occurs mainly due to the reconnection of the once isolated PV. Although provocation and elimination of the early pulmonary vein reconnection (EPVR) soon after PVI has been widely performed to improve the outcome, AF recurrence due to subsequent PV reconnections still occurs. In this study, we repeatedly provoked and eliminated the EPVR to determine the appropriate procedural end point.

Methods and results: Seventy-five patients with paroxysmal AF underwent PVI. EPVR was provoked by both time and ATP induction every 30 minutes until 90 minutes after the individual isolation of all PVs. The number of reconnected atrio-PV gaps were evaluated and reablated at each provocation step. Although both time- and ATP-dependent EPVR was induced most frequently at 30 minutes after PVI (75 and 76 gaps, respectively), the prevalence of induced EPVR at 60 minutes was still high (64 and 36 gaps induced by time and ATP, respectively). Only a small number of EPVR appeared at 90 minutes after the elimination of all EPVR by 60 minutes (8 gaps, P<0.01). During the mean follow-up period of 370 days, 92% of cases were free from AF without antiarrhythmic drugs.

Conclusions: Provocation and elimination of time- and ATP-induced EPVR not only at 30 minutes but also at 60 minutes is recommended after PVI to improve its efficacy.

MeSH terms

  • Adenosine Triphosphate / administration & dosage
  • Adenosine Triphosphate / pharmacology*
  • Atrial Fibrillation / epidemiology
  • Atrial Fibrillation / physiopathology
  • Atrial Fibrillation / surgery*
  • Catheter Ablation / methods*
  • Female
  • Follow-Up Studies
  • Heart Atria / physiopathology*
  • Heart Conduction System / drug effects*
  • Humans
  • Injections
  • Male
  • Middle Aged
  • Prevalence
  • Pulmonary Veins / physiology*
  • Pulmonary Veins / surgery*
  • Recurrence
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Adenosine Triphosphate